2019-04-12T15:35:22-05:00 2017-06-30 390859910 Baker Tilly Virchow Krause LLP 1650 Market Street Suite 4500 Philadelphia PA 191037341 990 2016-07-01 453533828 Biobat Inc BIOB 7188047835 450 Clarkson Avenue Brooklyn NY 11203 Craig P Campbell TREASURER 7188047835 2019-04-12 1 Julius C Green CPA P00350393 2159720701 X 50.243.90.186 2019-04-12 15:14:44 ED 1268292018190034ce01 2018-07-09 P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 927F87951D03751482A9914036EE93399D911F8E 2016 2019-02-21 02:37:17Z X eva cramer 450 Clarkson Avenue Brooklyn NY 11203 1816098 0 X n/a X 2010 NY Develop Space for new & growing biopharm tech companies to create a 21st century working waterfront. 11 11 0 3 0 0 0 0 1206728 1544552 0 0 20918 271546 1227646 1816098 0 0 0 0 253390 284513 0 0 0 2276375 2388518 2529765 2673031 -1302119 -856933 50460202 49866062 348532 104882 50111670 49761180 X The Corporation was formed to attract, encourage, develop, improve and assist the life science and technology industries and public and private R&D institutions in New York State by developing affordable biotechnology/science research (wet/dry lab) and manufacturing space in New York City. Approximately 486,000 square feet of space at the southern end of Building A in the Brooklyn Army Terminal is being developed for a science and technology community of tenants. At this time all of the developed Phase I space is occupied. 0 0 2350403 1544552 BioBAT holds a lease interest in a portion of the Brooklyn Army Terminal and is committed to creating a 21st Century working waterfront. Thus far Government funding has allowed BioBAT to acquire, maintain and develop this leasehold interest, as well as develop space for innovative companies to apply for occupancy and enter into leases for space. By providing these facilities and related support for the application, expansion and commercialization of biotechnology, life sciences, and hard sciences research at the Brooklyn Army Terminal, BioBAT fulfills its mission. The development of the space at BioBAT is being done in phases. Phase I is complete and fully occupied. Phase II is in development, with one current tenant and 60,000 square feet of space ready for development. BioBAT is in negotiations with several potential tenants to lease the remainder of the space. 2350403 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 X 4 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 1 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 NY X Kathleen Otto 7188047835 450 clarkson avenue brooklyn NY 11203 X Michael Lucchesi MD chair to 4/1/17 1.00 0.00 X X 0 0 0 Dr Wayne J Riley Chair from 4/3/17 to 6/30/17 1.00 0.00 X X 0 0 0 carolee fink vice chair 1.00 0.00 X X 0 0 0 Eva B Cramer PhD President 1.00 0.00 X X 0 0 0 Melanie Gehen Treasurer to 4/3/17 1.00 0.00 X X 0 0 0 Craig P Campbell treasurer as of 4/3/17 1.00 0.00 X X 0 0 0 robert sommer secretary 1.00 0.00 X X 0 0 0 joan bartolomeo director 1.00 0.00 X 0 0 0 christina derose director 1.00 0.00 X 0 0 0 dr james Dias director 1.00 0.00 X 0 0 0 dr andre fenton director to 6/1/17 1.00 0.00 X 0 0 0 matthew mroz director 1.00 0.00 X 0 0 0 William Stein director 1.00 0.00 X 0 0 0 Dr Prem Premsrirut director as of 6/15/17 1.00 0.00 X 0 0 0 kathleen otto executive director 45.00 0.00 X 165000 0 20480 165000 0 20480 1 0 1 0 0 RENTAL INCOME 532000 1544552 1544552 1544552 reimbursed expenses 900099 271546 271546 271546 1816098 1544552 0 271546 209438 48263 161175 75075 18769 56306 4417 4417 77626 30000 47626 13000 13000 1535 1535 9907 9043 864 3461 3115 346 228730 205857 22873 724 724 2000 2000 1148410 1148410 132385 132288 97 common area maintenance 420527 420527 repairs and maintence 333407 300066 33341 agency fees 11389 11389 charitable donations 1000 1000 2673031 2350403 322628 0 3303367 4703098 4011060 3123570 46497 197371 331229 328901 44299803 3413097 41912031 40886706 856018 626416 50460202 49866062 315596 93651 21705 11231 11231 348532 104882 X 50111670 49761180 50111670 49761180 50460202 49866062 -856933 506443 0 X 0 1 X 1 0 X 26331 1206728 1544552 2777611 26331 1206728 1544552 2777611 0 0 0 2777611 5 5 5 5 20918 271546 292464 26336 1227646 1816098 3070080 0.90470 0.98330 0.00000 X Schedule A, Part III, Line 12, Explanation of Other Income: Other Income - 2015 Amount: $ 20,918. reimbursed expenses - 2016 Amount: $ 271,546. 43687993 3360120 40327873 285402 10370 275032 29224 1048 28176 297184 41559 255625 40886706 tenant deposits 11231 11231 X 8134098 6318000 6318000 1816098 0 1816098 8991031 6318000 6318000 2673031 0 2673031 Part X, Line 2: Management has evaluated the Corporation's tax positions and concluded that the Corporation has not taken any uncertain tax positions that require adjustment to the financial statements to comply with the provisions of ASC 740. X 0 0 0 0 0 0 0 0 0 kathleen otto executive director 165000 0 0 0 0 0 12337 0 8143 0 185480 0 0 0 amended statement THE ORGANIZATION IS AMENDING ITS FORM 990 to correct rental income previously reported and adjust rent receivable on the balance sheet: THE FOLLOWING PARTS OF THE TAX RETURN WERE AFFECTED BY THE ADJUSTMENT: PART I - SUMMARY PART III - REVENUE BY PROGRAM PART VIII - STATEMENT OF REVENUE PART X - BALANCE SHEET PART XI - RECONCILIATION OF NET ASSETS SCHEDULE A - PART III - SUPPORT SCHEDULE FOR ORGANIZATIONS IN SECTION 509(A)(2) Schedule D - Part XI - Reconciliation of Revenue per Audited Financial Statements with Revenue per Return Form 990, Part V, Line 2b: THE EXECUTIVE DIRECTOR IS COMPENSATED FROM The Research Foundation of the State University of New York. Form 990, Part VI, Section A, line 2 BIOBAT IS CHARGED WITH MAINTAINING AND DEVELOPING 486,000 SQ FT OF THE BROOKLYN ARMY TERMINAL FOR LIFE SCIENCE TENANTS. THE BUILDING IS OWNED BY THE CITY OF NEW YORK AND MANAGED BY THE NYCEDC (New York City Economic Development Corporation). The NYCEDC effectively appoints 50% of the Biobat Board of Directors. Any costs incurred by BioBAT for building work done by EDC (Economic Development Corporation), e.g. sprinkler system, are reimbursed to EDC annually. In FY2018 BioBAT will have Penguin/EMCOR managing the facility. BIOBAT IS BECOMING MORE AND MORE INDEPENDENT AND AT SOME POINT WE WILL NOT NEED TO USE NYCEDC MAINTENANCE AND REPAIR SERVICES. Form 990, Part VI, Section A, line 7a IN ACCORDANCE WITH THE BYLAWS OF THE ORGANIZATION, THE BOARD OF DIRECTORS SHALL BE APPOINTED BY THE CORPORATE MEMBERS. FOUR OF THE DIRECTORS SHALL BE NAMED BY THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, FOUR SHALL BE NAMED BY THE NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION AND TWO SHALL BE ELECTED JOINTLY BY THE MEMBERS. Form 990, Part VI, Section B, line 11b THE 990 IS MADE AVAILABLE TO THE BOARD AND 990 IS REVIEWED BY THE AUDIT COMMITTEE. Form 990, Part VI, Section B, line 12c Each trustee, principal officer and member of a committee with governing board delegated powers shall annually sign a statement which affirms such person: (a) has received a copy of the Conflicts of Interest Policy; (b) has read and understands the policy; (c) has agreed to comply with the policy; and (d) understands the Corporation is charitable and in order to maintain its federal tax exemption it must engage primarily in activities which accomplish one or more of its tax-exempt purposes. To ensure the Corporation operates in a manner consistent with charitable purposes and does not engage in activities that could jeopardize its tax-exempt status, periodic reviews shall be conducted by the audit committee. Form 990, Part VI, Section C, line 19 The governing documents, conflict of interest policy and financial statements are available upon request.